Angermeyer, M. C. & Matschinger, H. (2005) Causal beliefs and attitudes to people with schizophrenia. Trend analysis based on data from two population surveys in Germany. British Journal of Psychiatry, 186
et al (2006) Decreased risk of suicides and attempts during lithium treatment: a meta-analytic review. Bipolar Disorders, 8
et al (2003) Lithium augmentation in refractory depression: clinical evidence and neurobiological mechanisms. Canadian Journal of Psychiatry, 48
Bentall, R. P. (2004) Madness Explained: Psychosis and Human Nature. Penguin Books.
Cade, J. F. (1975) Lithium – when why and how?
Medical Journal of Australia, 1 (22) 684–686.
Craddock, N. & Owen, M. J. (2005) The beginning of the end for the Kraepelinian dichotomy. British Journal of Psychiatry, 186
Cunningham Owens, D. G.
et al (2001) A randomized controlled trial of a brief interventional package for schizophrenic out-patients. Acta Psychiatrica Scandinavica, 103
Gartside, S. E.
Leitch, M. M. & Young, A. H. (2003) Altered glucocorticoid rhythm attenuates the ability of a chronic SSRI to elevate forebrain 5-HT: implications for the treatment of depression. Neuropsychopharmacology, 28
Geddes, J. R.
et al (2004) Long term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry, 161
Guze, S. B. (1989) Biological psychiatry: is there any other kind?
Psychological Medicine, 19
Hall, W. (2006) Is cannabis use psychotogenic?
et al (1988) Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45
Kendell, R. E. (1975) The Role of Diagnosis in Psychiatry. Blackwell.
Kendell, R. E. (2001) The distinction between mental and physical illness. British Journal of Psychiatry, 178
Kendell, R. E. & Zeally, A. K. (1988) Companion to Psychiatric Studies. Churchill Livingstone.
Kingdon, D. (2006a) Health research funding: mental health research continues to be underfunded. BMJ, 332
Kingdon, D. (2006b) Psychological and social interventions for schizophrenia. BMJ, 333
Kingdon, D. G. & Turkington, D. (2005) Cognitive Therapy of Schizophrenia. Guilford.
Sharma, T. & Hart, D. (2004) What attitudes do psychiatrists hold towards people with mental illness?
Psychiatric Bulletin, 28
et al (2007) Acceptable terminology and subgroups in schizophrenia: an exploratory study. Social Psychiatry and Psychiatric Epidemiology
et al (2006) Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a multicenter study. Neuropsychopharmacology, 31
et al (2005) History of the discovery and clinical introduction of chlorpromazine. Annals of Clinical Psychiatry, 17
Meaney, M. J. & Szyf, M. (2005) Maternal care as a model for experience-dependent chromatin plasticity?
Trends in Neurosciences, 28
Delespaul, P. & Van, O. J. (2005) Behavioral sensitization to daily life stress in psychosis. Psychological Medicine, 35
Nitrini, R. (2005) The cure of one of the most frequent types of dementia: a historical parallel. Alzheimer Disease and Associated Disorders, 19
et al (2005) Insight into schizophrenia: the effects of cognitive behavioural therapy on the components of insight and association with sociodemographics – data on a previously published randomised controlled trial. Schizophrenia Research, 74
et al (2003) Sexual and physical abuse during childhood and adulthood as predictors of hallucinations delusions and thought disorder. Psychology and Psychotherapy, 76
Teskey, P. (2006) What's in a name? A case for changing the ‘S’ word. Schizophrenia Digest, 4
Ritchie, J. C.
et al (2004) Hypothalamic–pituitary–adrenal axis function in patients with bipolar disorder. British Journal of Psychiatry, 184
Smith, M. S.
et al (2006) The dex/CRH test-is it better than the DST?
Young, A. H.
et al (2004) Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology, 29